CVRx, Inc. (CVRX) Stock Analysis & Investment Frameworks
CVRx, Inc. (CVRX) stock analysis on Invetso. Review CVRx, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
CVRx, Inc. Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
CVRx, Inc. Key Financial Metrics
- Market Cap: $41.83M
- Revenue: $56.65M
- ROE: -152.35%
- ROIC: -59.64%
- Dividend Yield: N/A
About CVRx, Inc.
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories. Incorporated in 2000, CVRx, Inc. is headquartered in Minneapolis, Minnesota.
CVRx, Inc. Investment Frameworks
Invetso analyzes CVRx, Inc. (CVRX) across the following frameworks:
- CVRx, Inc. 10Y Growth Potential
- CVRx, Inc. Scenario Analysis
- CVRx, Inc. Risks & Opportunities
- CVRx, Inc. Economic Moat
- CVRx, Inc. Business Model
- CVRx, Inc. Management
- CVRx, Inc. SWOT Analysis
- CVRx, Inc. Porter's 5 Forces
- CVRx, Inc. PESTLE Analysis
- CVRx, Inc. ESG Analysis